Literature DB >> 34697639

Biomarker-based risk scores in atrial fibrillation.

Ziad Hijazi1,2, Nicholas L Mills3, Christian Mueller4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34697639      PMCID： PMC8648390          DOI： 10.1093/ehjacc/zuab088

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN： 2048-8726


× No keyword cloud information.
  6 in total

1.  The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study.

Authors:  Ziad Hijazi; Jonas Oldgren; Johan Lindbäck; John H Alexander; Stuart J Connolly; John W Eikelboom; Michael D Ezekowitz; Claes Held; Elaine M Hylek; Renato D Lopes; Agneta Siegbahn; Salim Yusuf; Christopher B Granger; Lars Wallentin
Journal:  Lancet       Date:  2016-04-04       Impact factor: 79.321

Review 2.  Application of Biomarkers for Risk Stratification in Patients with Atrial Fibrillation.

Authors:  Ziad Hijazi; Jonas Oldgren; Agneta Siegbahn; Lars Wallentin
Journal:  Clin Chem       Date:  2016-11-03       Impact factor: 8.327

3.  2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.

Authors:  Gerhard Hindricks; Tatjana Potpara; Nikolaos Dagres; Elena Arbelo; Jeroen J Bax; Carina Blomström-Lundqvist; Giuseppe Boriani; Manuel Castella; Gheorghe-Andrei Dan; Polychronis E Dilaveris; Laurent Fauchier; Gerasimos Filippatos; Jonathan M Kalman; Mark La Meir; Deirdre A Lane; Jean-Pierre Lebeau; Maddalena Lettino; Gregory Y H Lip; Fausto J Pinto; G Neil Thomas; Marco Valgimigli; Isabelle C Van Gelder; Bart P Van Putte; Caroline L Watkins
Journal:  Eur Heart J       Date:  2021-02-01       Impact factor: 29.983

4.  Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial.

Authors:  Kazuma Oyama; Robert P Giugliano; David D Berg; Christian T Ruff; Petr Jarolim; Minao Tang; Sabina A Murphy; Hans J Lanz; Michael A Grosso; Elliott M Antman; Eugene Braunwald; David A Morrow
Journal:  Eur Heart J       Date:  2021-05-01       Impact factor: 29.983

5.  Biomarker-Based Risk Prediction With the ABC-AF Scores in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation.

Authors:  Alexander P Benz; Ziad Hijazi; Johan Lindbäck; Stuart J Connolly; John W Eikelboom; Jonas Oldgren; Agneta Siegbahn; Lars Wallentin
Journal:  Circulation       Date:  2021-04-14       Impact factor: 29.690

6.  The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation.

Authors:  Ziad Hijazi; Johan Lindbäck; John H Alexander; Michael Hanna; Claes Held; Elaine M Hylek; Renato D Lopes; Jonas Oldgren; Agneta Siegbahn; Ralph A H Stewart; Harvey D White; Christopher B Granger; Lars Wallentin
Journal:  Eur Heart J       Date:  2016-02-25       Impact factor: 29.983
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.